GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (OTCPK:DTXMF) » Definitions » EV-to-Revenue

Deltex Medical Group (Deltex Medical Group) EV-to-Revenue : 2.03 (As of Jun. 02, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Deltex Medical Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Deltex Medical Group's enterprise value is $4.56 Mil. Deltex Medical Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2.25 Mil. Therefore, Deltex Medical Group's EV-to-Revenue for today is 2.03.

The historical rank and industry rank for Deltex Medical Group's EV-to-Revenue or its related term are showing as below:

DTXMF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.65   Med: 1.79   Max: 5.14
Current: 2.02

During the past 13 years, the highest EV-to-Revenue of Deltex Medical Group was 5.14. The lowest was 0.65. And the median was 1.79.

DTXMF's EV-to-Revenue is ranked better than
65.22% of 828 companies
in the Medical Devices & Instruments industry
Industry Median: 3.23 vs DTXMF: 2.02

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-02), Deltex Medical Group's stock price is $0.003. Deltex Medical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Therefore, Deltex Medical Group's PS Ratio for today is 1.50.


Deltex Medical Group EV-to-Revenue Historical Data

The historical data trend for Deltex Medical Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltex Medical Group EV-to-Revenue Chart

Deltex Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.86 3.57 4.34 3.48 2.11

Deltex Medical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.34 - 3.48 - 2.11

Competitive Comparison of Deltex Medical Group's EV-to-Revenue

For the Medical Devices subindustry, Deltex Medical Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deltex Medical Group's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Deltex Medical Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Deltex Medical Group's EV-to-Revenue falls into.



Deltex Medical Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Deltex Medical Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4.564/2.245
=2.03

Deltex Medical Group's current Enterprise Value is $4.56 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Deltex Medical Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deltex Medical Group  (OTCPK:DTXMF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Deltex Medical Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.003/0.002
=1.50

Deltex Medical Group's share price for today is $0.003.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deltex Medical Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Deltex Medical Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Deltex Medical Group (Deltex Medical Group) Business Description

Traded in Other Exchanges
Address
Terminus Road, Chichester, W Sussex, GBR, PO19 8TX
Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.

Deltex Medical Group (Deltex Medical Group) Headlines

No Headlines